| Bioactivity | Trastuzumab MMAF is a HER2 targeted antiboy-active molecular conjugate (ADCs). Trastuzumab MMAF is derived from humanized IgG1 monoclonal antibody Trastuzumab (HY-P9907), Consists of a tubulin polymerization inhibitor MMAF (HY-15579) and a cleavable ADC linker Val-Cit (HY-140014). Trastuzumab MMAF can be used in cancer research[1]. |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yao X, et al. A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity[J]. Breast cancer research and treatment, 2015, 153: 123-133. |